Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,014Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Novartis Pharma Schweizerhalle AG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Asiminib hydrochloride

Registrant Name : Novartis Korea Co., Ltd.

Registration Date : 2024-11-20

Registration Number : Su196-31-ND

Manufacturer Name : Novartis Pharma Schweizerhal...

Manufacturer Address : Rothausstrasse, 4133, Pratteln, Switzerland

blank

Looking for 1492952-76-7 / Asciminib API manufacturers, exporters & distributors?

Asciminib manufacturers, exporters & distributors 1

24

PharmaCompass offers a list of Asciminib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Asciminib manufacturer or Asciminib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Asciminib manufacturer or Asciminib supplier.

PharmaCompass also assists you with knowing the Asciminib API Price utilized in the formulation of products. Asciminib API Price is not always fixed or binding as the Asciminib Price is obtained through a variety of data sources. The Asciminib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Asciminib

Synonyms

Abl-001, 1492952-76-7, Abl001, Asciminib free base, Abl001-nx, Nvp-abl001

Cas Number

1492952-76-7

Unique Ingredient Identifier (UNII)

L1F3R18W77

About Asciminib

Asciminib is an orally bioavailable, allosteric Bcr-Abl1 tyrosine kinase inhibitor, with antineoplastic activity. Upon administration, asciminib targets and binds to the myristoyl pocket of the Bcr-Abl1 fusion protein at a location that is distinct from the ATP-binding domain, thereby inhibiting the activity of both wild-type Bcr-Abl and certain mutation forms, including the T315I mutation. This binding results in the inhibition of Bcr-Abl1-mediated proliferation and enhanced apoptosis of Philadelphia chromosome-positive (Ph+) hematological malignancies. The Bcr-Abl1 fusion protein tyrosine kinase is an abnormal enzyme produced by leukemia cells that contain the Philadelphia chromosome.

asciminib hydrochloride Manufacturers

A asciminib hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of asciminib hydrochloride, including repackagers and relabelers. The FDA regulates asciminib hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. asciminib hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of asciminib hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

asciminib hydrochloride Suppliers

A asciminib hydrochloride supplier is an individual or a company that provides asciminib hydrochloride active pharmaceutical ingredient (API) or asciminib hydrochloride finished formulations upon request. The asciminib hydrochloride suppliers may include asciminib hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of asciminib hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

asciminib hydrochloride KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a asciminib hydrochloride Drug Master File in Korea (asciminib hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of asciminib hydrochloride. The MFDS reviews the asciminib hydrochloride KDMF as part of the drug registration process and uses the information provided in the asciminib hydrochloride KDMF to evaluate the safety and efficacy of the drug.

After submitting a asciminib hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their asciminib hydrochloride API can apply through the Korea Drug Master File (KDMF).

click here to find a list of asciminib hydrochloride suppliers with KDMF on PharmaCompass.

asciminib hydrochloride Manufacturers | Traders | Suppliers

asciminib hydrochloride Manufacturers, Traders, Suppliers 1
31

We have 1 companies offering asciminib hydrochloride

Get in contact with the supplier of your choice:

  1. Novartis Pharmaceuticals Corporation
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.